Skip to content
PeptideTech
sign in
live116 compounds · 15 vendors listed · 7 graded · audit of 4 Nov 2026 · prices checked 6 Nov 2026independent · grades can’t be bought

Home / Research library / Syn-AKE

Peptides

Syn-AKE: molecular data, studies & sources

Syn-AKE is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF)
C23H37N5O7
Molecular weight (MW)
495.6 g/mol
PubChem compound ID
71465152
Record title
Dipeptide diaminobutyroyl benzylamide diacetate

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 71465152 · retrieved 2026-09-21

2D molecular structure for Syn-AKE, PubChem CID 71465152
2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.
Chemical identifiers and source data
IUPAC name
acetic acid;(2S)-N-[(2S)-4-amino-1-(benzylamino)-1-oxobutan-2-yl]-1-(3-aminopropanoyl)pyrrolidine-2-carboxamide
InChIKey
HSUGRPOJOBRRBK-SXBSVMRRSA-N
SMILES
CC(=O)O.CC(=O)O.C1C[C@H](N(C1)C(=O)CCN)C(=O)N[C@@H](CCN)C(=O)NCC2=CC=CC=C2
Machine-readable PubChem source

Identifiers & sequence

PubChem CID
71465152
CAS Registry Number
823202-99-9via ChemIDplus, EPA DSSTox, FDA GSRS
FDA UNII
38H206R00R
InChIKey
HSUGRPOJOBRRBK-SXBSVMRRSA-N
Wikidata
Q27256785

Peptide sequence · 3 residues (one-letter code; X marks a residue without a one-letter code)

XPX

Condensed notation with terminal groups and non-standard residues

H-bAla-Pro-Dab-NHBn.2CH3CO2H

Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.

CAS numbers are published only from ChemIDplus, EPA DSSTox or the FDA Global Substance Registration System; UNII codes are confirmed in FDA GSRS by structure, sequence or exact name. Checked 2026-10-07.

Calculated molecular descriptors
Monoisotopic (exact) mass495.2693 Da
Heavy atoms35
Hydrogen-bond donors6
Hydrogen-bond acceptors7
Rotatable bonds9
Topological polar surface area205.2 Ų
Calculated logP (Crippen)-0.34
Rings2
Stereocenters2
Formal charge0

Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.

Registered clinical trials

Studies registered on ClinicalTrials.gov that list Dipeptide diaminobutyroyl benzylamide diacetate as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.

No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.

Registry check 2026-10-01 · Run this search on ClinicalTrials.gov

Human intervention studies

Selected studies in which participants received Dipeptide diaminobutyroyl benzylamide diacetate, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.

No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.

    Preclinical research, reviews & other publications

    Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

    1. Preclinical / laboratory research

      Anti-aging activity of Syn-Ake peptide by in silico approaches and in vitro tests.

      Gok B, Budama-Kilinc Y, Kecel-Gunduz S et al. · Journal of biomolecular structure & dynamics · 2024

      PMID 37349941 · DOI: 10.1080/07391102.2023.2223681

    Syn-AKE supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    Syn-AKE for sale: compare prices, sizes and forms from every tracked supplier →

    SupplierRecorded packagesExample source listing
    Cenexa LabsUSD200mg Powder1 recorded offers200mg Powder · $209.99Checked Nov 6, 2026Supplier listing, Syn-AKE 200mg Powder, Cenexa Labs, opens in a new tab

    Reference sources & further reading

    The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

    Search for additional research

    These links run searches; their results have not been individually reviewed and can include unrelated compounds.

    Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

    Related research profiles